Device Trial Radar · NCT07680296
NIR Device for Assessment of Skin Flap Perfusion in Breast Surgery: A Pilot Interventional Study
Last checked: Nov 19, 2026Latest source record: Jul 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Oct 10, 2024
Primary completion
Feb 13, 2026
Study completion Feb 13, 2026
Sponsor
- Lead sponsor
- National Research Council, Institute of Clinical Physiology, ItalyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 2, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this single-center, nonrandomized, interventional non-profit pilot study is to evaluate the feasibility and clinical utility of a non-invasive near-infrared spectroscopy (NIRS) imaging device for assessing skin-flap tissue oxygen saturation in adult women undergoing mastectomy and immediate breast reconstruction after oncological surgery. The main questions it aims to answer are: * Can NIRS imaging provide reproducible measurements of tissue oxygen saturation (StO₂) in mastectomy skin flaps before surgery, during the intraoperative phase, and during postoperative follow-up? * Can spatial and temporal variations in StO₂ identify areas of potentially reduced flap perfusion or impaired tissue viability? * Can NIRS-derived oxygenation measurements support the assessment of postoperative flap healing and ischemic complications? Participants will: * undergo non-invasive NIRS imaging of the breast skin flap before surgery; * undergo one intraoperative NIRS acquisition during mastectomy and immediate breast reconstruction; * undergo repeated NIRS imaging during postoperative follow-up visits; * receive standard surgical treatment and postoperative care according to routine clinical practice. NIRS imaging is performed for study purposes and does not influence intraoperative surgical decision-making or the choice of reconstructive procedure.
Conditions
- Breast Cancer
- Breast Reconstruction
- Mastectomy
Interventions
Snapshot NIR V3.0Device
The Snapshot NIR V3.0 device is used to noninvasively assess superficial breast skin flap tissue oxygenation and perfusion. NIR images and tissue oxygen saturation measurements are acquired preoperatively, early postoperatively, and at a later postoperative assessment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tissue Oxygen Saturation (StO₂) Measured by the Snapshot NIR V3.0 DeviceTime frame: Baseline (preoperative), postoperative day 1, and postoperative day 15 (±5 days).
- Correlation Between Snapshot NIR Tissue Oxygen Saturation (StO₂) and Clinical Assessment of Breast Skin Flap PerfusionTime frame: Baseline (preoperative), postoperative day 1, and postoperative day 15 (±5 days).
- Temporal Change in Tissue Oxygen Saturation (StO₂) of Breast Skin FlapsTime frame: Baseline (preoperative), postoperative day 1, and postoperative day 15 (±5 days).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
U.O. Senologia, Azienda Ospedaliero-Universitaria Pisana (AOUP) Presidio Ospedaliero Santa Chiara
Pisa, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.